We also performed the Wilcoxon rank-sum test and the 80 key DDR pathway genes have significant differences between the NSCLC subtypes, such as XRCC5 and SHFM1 were significantly different between the subtypes (Figure 4F). This evidence concerns the gene XRCC5 and non-small cell lung carcinoma.